10.1038/s41586-019-1705-2 18 BerteroT.OldhamW
Control-IQ technology: Control-IQ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values
In some embodiments, the auris gel formulation contains a viscosity enhancing agent sufficient to provide a viscosity of from about 50,0000 to about 3,000,000 centipoise
TB-500 supports cell migration, differentiation, angiogenesis, and anti-inflammatory responses, especially in damaged muscle, myocardium, and epithelium
In a systematic review published in the journal Diabetes & Metabolic Syndrome: Clinical Research & Reviews , authors have described the therapeutic potency of citrus bioflavonoids in controlling blood glucose levels and metabolic complications in patients with type 2 diabetes